Showing results (631-640 of 831) with videos related to
Sort By:
Pageof 84
American Journal of Hematology|May 29, 2015
Bone marrow necrosis in acute leukemia: Clinical characteristic and outcomeTalha Badar, Aditya Shetty, Carlos Bueso-Ramos, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 8, 2015
Outcomes of Patients With Chronic Lymphocytic Leukemia and Richter's Transformation After Transplantation FailureUri Rozovski, Ohad Benjamini, Preetesh Jain, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 2, 2003
Adaptive randomized study of idarubicin and cytarabine versus troxacitabine and cytarabine versus troxacitabine and idarubicin in untreated patients 50 years or older with adverse karyotype acute myeloid leukemiaFrancis J Giles, Hagop M Kantarjian, Jorge E Cortes, et al.Cancer|April 5, 2002
Simultaneous homoharringtonine and interferon-alpha in the treatment of patients with chronic-phase chronic myelogenous leukemiaSusan O'Brien, Moshe Talpaz, Jorge Cortes, et al.Blood|February 15, 2007
Prognostic nomogram and index for overall survival in previously untreated patients with chronic lymphocytic leukemiaWilliam G Wierda, Susan O'Brien, Xuemei Wang, et al.Blood|May 15, 2010
First report of phase 2 study of dasatinib with hyper-CVAD for the frontline treatment of patients with Philadelphia chromosome-positive (Ph+) acute lymphoblastic leukemiaFarhad Ravandi, Susan O'Brien, Deborah Thomas, et al.The Journal of Molecular Diagnostics : JMD|January 1, 2013
Genomic variation by whole-genome SNP mapping arrays predicts time-to-event outcome in patients with chronic lymphocytic leukemia: a comparison of CLL and HapMap genotypesCarmen D Schweighofer, Kevin R Coombes, Tadeusz Majewski, et al.Molecular Cancer|June 4, 2013
Signal transducer and activator of transcription (STAT)-3 regulates microRNA gene expression in chronic lymphocytic leukemia cellsUri Rozovski, George A Calin, Tetsuro Setoyama, et al.American Journal of Hematology|August 6, 2013
Significance of deeper molecular responses in patients with chronic myeloid leukemia in early chronic phase treated with tyrosine kinase inhibitorsLorenzo Falchi, Hagop M Kantarjian, Xuemei Wang, et al.American Journal of Hematology|January 10, 2019
Prognostic implications of cytogenetics in adults with acute lymphoblastic leukemia treated with inotuzumab ozogamicinElias Jabbour, Anjali S Advani, Matthias Stelljes, et al.Pageof 84